DexCom
DXCM
#875
Rank
HK$223.41 B
Marketcap
HK$572.83
Share price
0.25%
Change (1 day)
-18.76%
Change (1 year)

Earnings for DexCom (DXCM)

Earnings in 2024: HK$5.69 Billion

According to DexCom's latest financial reports the company's current earnings are HK$4.51 Billion. In 2024 the company made an earning of HK$5.69 Billion a decrease over its 2023 earnings that were of HK$5.71 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for DexCom from 2005 to 2024

Annual earnings

Year Earnings Change
2024HK$5.69 B-0.37%
2023HK$5.71 B78.13%
2022HK$3.20 B47.34%
2021HK$2.17 B-10.11%
2020HK$2.42 B88.27%
2019HK$1.28 B-258.48%
2018-HK$0.82 Billion189.94%
2017-HK$0.28 Billion-44.24%
2016-HK$0.51 Billion12.43%
2015-HK$0.45 Billion165.58%
2014-HK$0.17 Billion-25.61%
2013-HK$0.23 Billion-48.11%
2012-HK$0.44 Billion24.5%
2011-HK$0.35 Billion
2008-HK$0.42 Billion13.18%
2007-HK$0.37 Billion-5.36%
2006-HK$0.39 Billion52.08%
2005-HK$0.26 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$253.31 B 3,212.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$63.63 B 732.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
HK$50.12 B 555.42%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Becton Dickinson
BDX
HK$14.71 B 92.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
HK$13.34 B 74.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-HK$1.61 Billion-120.95%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
-HK$8.89 Billion-216.18%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical Services
WST
HK$4.72 B-38.21%๐Ÿ‡บ๐Ÿ‡ธ USA